Myriam Labopin

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Éolia Brissot, Myriam Labopin, M. Beckers et al. · Haematologica · 2014 · 162 citations · Full text

Medicine, Hematology, Oncology +17

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

Charles Craddock, Myriam Labopin, Marie Robin et al. · Haematologica · 2016 · 142 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Societe Francophone d'Histocompatibilite et d'Immunogenetique (SFHI) and Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) analysis

Annalisa Ruggeri, Vanderson Rocha, Emeline Masson et al. · Haematologica · 2012 · 134 citations · Full text

Life Sciences, Hematology, Immunology +17

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia

Francesco Frassoni, Myriam Labopin, R Powles et al. · The Lancet · 2000 · 106 citations

Medicine, Hematology, Oncology +14

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

Simona Piemontese, F. Ciceri, Myriam Labopin et al. · Journal of Hematology & Oncology · 2017 · 83 citations · Full text

Medicine, Hematology, Immunology +17